Neurodegenerative Disease Management (ISSN: 1758-2024)

Description

Neurodegenerative Disease Management presents findings, analysis and commentary in the ongoing battle with this range of debilitating illnesses. The journal provides guidance to the multidisciplinary disease management community regarding the most effective treatment strategies and the implications of cutting-edge research as it emerges.
Topics covered include:
All neurodegenerative diseases, including Alzheimer's, Parkinson's, Huntington's, ALS, epilepsy and multiple sclerosis
Disease mechanisms
Epidemiology
Genetic and environmental influences on disease pathogenesis
Clinical manifestations and diagnosis of disease
Use of biomarkers in diagnosis and prognosis
Therapeutic options
Evaluation and management of cognitive impairment and dementia
Prospects for new treatments such as cell and gene therapy
Medical treatment guidelines
Adverse events and drug safety
Pharmacoeconomics, outcomes research, real-world evidence and quality of life
Disease management in developed and developing countries
Palliative care
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.